These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
164 related items for PubMed ID: 23634282
1. Slug increases sensitivity to tubulin-binding agents via the downregulation of βIII and βIVa-tubulin in lung cancer cells. Tamura D, Arao T, Nagai T, Kaneda H, Aomatsu K, Fujita Y, Matsumoto K, De Velasco MA, Kato H, Hayashi H, Yoshida S, Kimura H, Maniwa Y, Nishio W, Sakai Y, Ohbayashi C, Kotani Y, Nishimura Y, Nishio K. Cancer Med; 2013 Apr; 2(2):144-54. PubMed ID: 23634282 [Abstract] [Full Text] [Related]
2. Delineating the Role of βIV-Tubulins in Pancreatic Cancer: βIVb-Tubulin Inhibition Sensitizes Pancreatic Cancer Cells to Vinca Alkaloids. Sharbeen G, McCarroll J, Liu J, Youkhana J, Limbri LF, Biankin AV, Johns A, Kavallaris M, Goldstein D, Phillips PA. Neoplasia; 2016 Dec; 18(12):753-764. PubMed ID: 27889644 [Abstract] [Full Text] [Related]
3. Class III beta-tubulin mediates sensitivity to chemotherapeutic drugs in non small cell lung cancer. Gan PP, Pasquier E, Kavallaris M. Cancer Res; 2007 Oct 01; 67(19):9356-63. PubMed ID: 17909044 [Abstract] [Full Text] [Related]
4. betaIII-tubulin is a multifunctional protein involved in drug sensitivity and tumorigenesis in non-small cell lung cancer. McCarroll JA, Gan PP, Liu M, Kavallaris M. Cancer Res; 2010 Jun 15; 70(12):4995-5003. PubMed ID: 20501838 [Abstract] [Full Text] [Related]
5. βII-tubulin and βIII-tubulin mediate sensitivity to peloruside A and laulimalide, but not paclitaxel or vinblastine, in human ovarian carcinoma cells. Kanakkanthara A, Northcote PT, Miller JH. Mol Cancer Ther; 2012 Feb 15; 11(2):393-404. PubMed ID: 22180309 [Abstract] [Full Text] [Related]
6. Microtubule dynamics, mitotic arrest, and apoptosis: drug-induced differential effects of betaIII-tubulin. Gan PP, McCarroll JA, Po'uha ST, Kamath K, Jordan MA, Kavallaris M. Mol Cancer Ther; 2010 May 15; 9(5):1339-48. PubMed ID: 20442307 [Abstract] [Full Text] [Related]
7. Epithelial mesenchymal transition is required for acquisition of anoikis resistance and metastatic potential in adenoid cystic carcinoma. Jia J, Zhang W, Liu JY, Chen G, Liu H, Zhong HY, Liu B, Cai Y, Zhang JL, Zhao YF. PLoS One; 2012 May 15; 7(12):e51549. PubMed ID: 23272116 [Abstract] [Full Text] [Related]
8. Non-adherent culture induces paclitaxel resistance in H460 lung cancer cells via ERK-mediated up-regulation of βIVa-tubulin. Atjanasuppat K, Lirdprapamongkol K, Jantaree P, Svasti J. Biochem Biophys Res Commun; 2015 Oct 23; 466(3):493-8. PubMed ID: 26375501 [Abstract] [Full Text] [Related]
9. Bcl-2 down-regulation and tubulin subtype composition are involved in resistance of ovarian cancer cells to vinflunine. Estève MA, Carré M, Bourgarel-Rey V, Kruczynski A, Raspaglio G, Ferlini C, Braguer D. Mol Cancer Ther; 2006 Nov 23; 5(11):2824-33. PubMed ID: 17121929 [Abstract] [Full Text] [Related]
10. Pellino-1 promotes lung carcinogenesis via the stabilization of Slug and Snail through K63-mediated polyubiquitination. Jeon YK, Kim CK, Hwang KR, Park HY, Koh J, Chung DH, Lee CW, Ha GH. Cell Death Differ; 2017 Mar 23; 24(3):469-480. PubMed ID: 28009353 [Abstract] [Full Text] [Related]
11. Study of multi-drug resistant mechanisms in a taxol-resistant hepatocellular carcinoma QGY-TR 50 cell line. Zhou J, Cheng SC, Luo D, Xie Y. Biochem Biophys Res Commun; 2001 Feb 09; 280(5):1237-42. PubMed ID: 11162660 [Abstract] [Full Text] [Related]
12. microRNA-33a prevents epithelial-mesenchymal transition, invasion, and metastasis of gastric cancer cells through the Snail/Slug pathway. Chen DD, Cheng JT, Chandoo A, Sun XW, Zhang L, Lu MD, Sun WJ, Huang YP. Am J Physiol Gastrointest Liver Physiol; 2019 Aug 01; 317(2):G147-G160. PubMed ID: 30943047 [Abstract] [Full Text] [Related]
13. TUBB3/βIII-tubulin acts through the PTEN/AKT signaling axis to promote tumorigenesis and anoikis resistance in non-small cell lung cancer. McCarroll JA, Gan PP, Erlich RB, Liu M, Dwarte T, Sagnella SS, Akerfeldt MC, Yang L, Parker AL, Chang MH, Shum MS, Byrne FL, Kavallaris M. Cancer Res; 2015 Jan 15; 75(2):415-25. PubMed ID: 25414139 [Abstract] [Full Text] [Related]
14. Tubulin binding cofactor C (TBCC) suppresses tumor growth and enhances chemosensitivity in human breast cancer cells. Hage-Sleiman R, Herveau S, Matera EL, Laurier JF, Dumontet C. BMC Cancer; 2010 Apr 12; 10():135. PubMed ID: 20384997 [Abstract] [Full Text] [Related]
15. Marine Bacterial Polysaccharide EPS11 Inhibits Cancer Cell Growth via Blocking Cell Adhesion and Stimulating Anoikis. Cao R, Jin W, Shan Y, Wang J, Liu G, Kuang S, Sun C. Mar Drugs; 2018 Mar 08; 16(3):. PubMed ID: 29518055 [Abstract] [Full Text] [Related]
16. Hypoxia inducible factor-1 influences sensitivity to paclitaxel of human lung cancer cell lines under normoxic conditions. Zeng L, Kizaka-Kondoh S, Itasaka S, Xie X, Inoue M, Tanimoto K, Shibuya K, Hiraoka M. Cancer Sci; 2007 Sep 08; 98(9):1394-401. PubMed ID: 17608771 [Abstract] [Full Text] [Related]
17. Slug is upregulated during wound healing and regulates cellular phenotypes in corneal epithelial cells. Aomatsu K, Arao T, Abe K, Kodama A, Sugioka K, Matsumoto K, Kudo K, Kimura H, Fujita Y, Hayashi H, Nagai T, Shimomura Y, Nishio K. Invest Ophthalmol Vis Sci; 2012 Feb 16; 53(2):751-6. PubMed ID: 22247468 [Abstract] [Full Text] [Related]
18. hRAD9 functions as a tumor suppressor by inducing p21-dependent senescence and suppressing epithelial-mesenchymal transition through inhibition of Slug transcription. Wen FC, Chang TW, Tseng YL, Lee JC, Chang MC. Carcinogenesis; 2014 Jul 16; 35(7):1481-90. PubMed ID: 24403312 [Abstract] [Full Text] [Related]
19. Induction of stem cell factor/c-Kit/slug signal transduction in multidrug-resistant malignant mesothelioma cells. Catalano A, Rodilossi S, Rippo MR, Caprari P, Procopio A. J Biol Chem; 2004 Nov 05; 279(45):46706-14. PubMed ID: 15337769 [Abstract] [Full Text] [Related]
20. Antimitotic and tubulin-interacting properties of vinflunine, a novel fluorinated Vinca alkaloid. Kruczynski A, Barret JM, Etiévant C, Colpaert F, Fahy J, Hill BT. Biochem Pharmacol; 1998 Mar 01; 55(5):635-48. PubMed ID: 9515574 [Abstract] [Full Text] [Related] Page: [Next] [New Search]